Skip to content

Comparison between the Efficiency of Cinnarizine and Topiramate in the treatment of Vestibular Migraine

Comparison between the Efficiency of Cinnarizine and Topiramate in the treatment of Vestibular Migraine

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR201909600414183
Enrollment
72
Registered
2019-09-30
Start date
2018-01-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear, Nose and Throat

Interventions

topiramate

Sponsors

faculty of medicine menoufya university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. At least five episodes with vestibular symptoms of moderate or severe intensity, each lasting 5 min to 72 h B. Current or previous history of migraine with or without aura according to the International Classification of Headache Disorders (ICHD) C. One or more migraine features with at least 50% of the vestibular episodes: • Headache with at least two of the following characteristics: one-sided location, pulsating quality, moderate or severe pain intensity, or aggravation by routine physical activity • Photophobia and phonophobia • Visual aura D. Not better accounted for by another vestibular or ICHD diagnosis.

Exclusion criteria

Exclusion criteria: age more than 60 years age less than 18 years

Design outcomes

Primary

MeasureTime frame
the change in monthly frequency of vertigo attacks and migraine attacks during the study , duration of attacks

Secondary

MeasureTime frame
The cost of the therapy and incidence of side effects

Countries

Egypt

Contacts

Public Contactnancy omran

audiology resident

doctornana2012@gmail.com00201007270804

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026